Antiatherosclerotic activity of drugs in relation to nitric oxide function

European Journal of Pharmacology

Volumn 375, Issue 1-3, 1999, Pages 157-176

  Bult, Hidde ^a   Herman, Arnold G ^a   Matthys, Katelijne E ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Cardiovascular disease; Nitric oxide (NO); Vascular endothelium

Indexed keywords

ANTILIPEMIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BUTYLCRESOL; CALCIUM ANTAGONIST; COLESTYRAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; FENOFIBRATE; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; GEMFIBROZIL; MEVALONIC ACID; MEVINOLIN; NITRIC OXIDE; ORGANIC NITRATE; PRAVASTATIN; PROBUCOL; SIMVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; PRIORITY JOURNAL; RAT; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS; ENDOTHELIUM, VASCULAR; HUMANS; NITRIC OXIDE;

EID: 0033019877     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00328-3     Document Type: Review

References (200)

1. Adams M.R., Jessup W., Celermajer D.S. Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: reversibility with oral L-arginine but not vitamin C. J. Am. Coll. Cardiol. 29:1997;491-497.
2. Aengevaeren W.R., Uijen G.J., Jukema J.W., Bruschke A.V., van der Werf T. Functional evaluation of lipid-lowering therapy by pravastatin in the Regression Growth Evaluation Statin Study (REGRESS). Circulation. 96:1997;429-435.
3. Akishita M., Ouchi Y., Miyoshi H., Kozaki K., Inoue S., Ishikawa M., Eto M., Toba K., Orimo H. Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: effects on migration and proliferation of vascular smooth muscle cells. Atherosclerosis. 130:1997;1-10.
4. Anderson T.J., Meredith I.T., Yeung A.C., Frei B., Selwyn A.P., Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N. Engl. J. Med. 332:1995;488-493.
5. Andrews T.C., Raby K., Barry J., Naimi C.L., Allred E., Ganz P., Selwyn A.P. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease. Circulation. 95:1997;324-328.
6. Arnal J.F., Clamens S., Pechet C., Negre-Salvayre A., Allera C., Girolami J.-P., Salvayre R., Bayard F. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc. Natl. Acad. Sci. U.S.A. 93:1996;4108-4113.
7. Azen S.P., Qian D., Mack W.J., Sevanian A., Selzer R.H., Liu C.R., Liu C.H., Hodis H.N. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering. Circulation. 94:1996;2369-2372.
8. Baldassarre D., Franceschini G., Peruzzotti G., Brusoni B., Sirtori C.R. Clinical evaluation of probucol in hypercholesteremia: individual lipoprotein responses and inhibitory effect on carotid atherosclerosis progression. J. Cardiovasc. Pharmacol. 30:1997;784-789.
9. Barbul, A., 1990. Physiology and pharmacology of arginine. In: Moncada, S., Higgs, E.A. (Eds.), Nitric Oxide from L-Arginine: A Bioregulatory System, Elsevier, Amsterdam, pp. 317-329.
10. Bast A., Haenen G.R., Doelman C.J. Oxidants and antioxidants: state of the art. Am. J. Med. 91:1991;2S-13S.
11. Beetens J.R., Coene M.-C., Verheyen A., Zonnekeyn L.L., Herman A.G. Vitamin C increases the prostacyclin production and decreases the vascular lesions in experimental atherosclerosis in rabbits. Prostaglandins. 32:1986;335-352.
12. Bellosta S., Bernini F., Ferri N., Quarato P., Canavesi M., Arnaboldi L., Fumagalli R., Paoletti R., Corsini A. Direct vascular effects of HMG-CoA reductase inhibitors. Atherosclerosis. 137:1998;S101-S109. Suppl.
13. Benson G.M., Schiffelers R., Nicols C., Latcham J., Vidgeon-Hart M., Toseland C.D., Suckling K.E., Groot P.H. Effect of probucol on serum lipids, atherosclerosis and toxicology in fat-fed LDL receptor deficient mice. Atherosclerosis. 141:1998;237-247.
14. Binko J., Murphy T.V., Majewski H. 17β-Oestradiol enhances nitric oxide synthase activity in endothelium-denuded rat aorta. Clin. Exp. Pharmacol. Physiol. 25:1998;120-127.
15. Bird D.A., Tangirala R.K., Fruebis J., Steinberg D., Witztum J.L., Palinski W. Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice. J. Lipid Res. 39:1998;1079-1090.
16. Birnbaum Y., Fishbein M.C., Luo H., Nishioka T., Siegel R.J. Regional remodeling of atherosclerotic arteries: a major determinant of clinical manifestations of disease. J. Am. Coll. Cardiol. 30:1997;1149-1164.
17. Bocan T.M., Mueller S.B., Brown E.Q., Uhlendorf P.D., Mazur M.J., Newton R.S. Antiatherosclerotic effects of antioxidants are lesion-specific when evaluated in hypercholesterolemic New Zealand white rabbits. Exp. Mol. Path. 57:1992;70-83.
18. Bode-Böger S.M., Böger R.H., Alfke H., Heinzel D., Tsikas D., Creutzig A., Alexander K., Frölich J.C. L-Arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study. Circulation. 93:1996;85-90.
19. Bonthu S., Heistad D.D., Chappell D.A., Lamping K.G., Faraci F.M. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. Arterioscler. Thromb. Vasc. Biol. 17:1997;2333-2340.
20. Bourassa P.-A., Milos P.M., Gaynor B.J., Breslow J.L., Arello R.J. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 93:1996;10022-10027.
21. Böger R.H., Bode-Böger S.M., Brandes R.P., Phivthong-ngam L., Böhme M., Nafe R., Mügge A., Frölich J.C. Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin. Circulation. 96:1997;1282-1290.
22. Braesen J.H., Harsch M., Niendorf A. Survival and cardiovascular pathology of heterozygous Watanabe heritable hyperlipidaemic rabbits treated with pravastatin and probucol on a low-cholesterol (0.03%)-enriched diet. Virchows Arch. 432:1998;557-562.
23. Bult H., De Meyer G.R.Y., Herman A.G. Influence of chronic treatment with a nitric oxide donor on fatty streak development and reactivity of the rabbit aorta. Br. J. Pharmacol. 114:1995;1371-1382.
24. Buttery L.D.K., Springall D.R., Chester A.H., Evans T.J., Standfield N., Parums D.V., Yacoub M.H., Polak J.M. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab. Invest. 75:1996;77-85.
25. Carew T.E., Schwenke D.C., Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. U.S.A. 84:1987;7725-7729.
26. Cashin-Hemphill L., Holmvang G., Chan R.C., Pitt B., Dinsmore R.E., Lees R.S. Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial. Am. J. Cardiol. 83:1999;43-47.
27. Casino P.R., Kilcoyne C.M., Quyyumi A.A., Hoeg J.M., Panza J.A. Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients. J. Am. Coll. Cardiol. 23:1994;844-850.
28. 2+ mobilization. Circ. Res. 81:1997;885-892.
29. Chambers J.C., McGregor A., Jean-Marie J., Obeid O.A., Kooner J.S. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation. 99:1999;1156-1160.
30. Chen L., Haught W.H., Yang B., Saldeen T.G., Parathasarathy S., Mehta J.L. Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. J. Am. Coll. Cardiol. 30:1997;569-575.
31. Chen S.J., Li H., Durand J., Oparil S., Chen Y.F. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation. 93:1996;577-584.
32. Chobanian A.V., Hope S., Brecher P. Dissociation between the antiatherosclerotic effect of trandolapril and suppression of serum and aortic angiotensin-converting enzyme activity in the Watanabe heritable hyperlipidemic rabbit. Hypertension. 25:1995;1306-1310.
33. Cleland J.G.F., Krikler D.M. Modification of atherosclerosis by agents that do not lower cholesterol. Br. Heart J. 69:1993;S54-S62.
34. Cominacini L., Garbin U., Pasini A.F., Davoli A., Campagnola M., Contessi G.B., Pastorino A.M., Lo Cascio V. Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Radic. Biol. Med. 22:1997;117-127.
35. Cooke J.P., Andon N.A., Girerd X.J., Hirsch A.T., Creager M.A. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation. 83:1991;1057-1062.
36. Cooke J.P., Singer A.H., Tsao P., Zera P., Rowan R.A., Billingham M.E. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J. Clin. Invest. 90:1992;1168-1172.
37. Cooper A., Heagerty A.M. Endothelial dysfunction in human intramyocardial small arteries in atherosclerosis and hypercholesterolemia. Am. J. Physiol. 275:1998;H1482-H1488.
38. Crawford R.S., Kirk E.A., Rosenfeld M.E., LeBoeuf R.C., Chait A. Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 18:1998;1506-1513.
39. Creager M.A., Gallagher S.J., Girerd X.J., Coleman S.M., Dzau V.J., Cooke J.P. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J. Clin. Invest. 90:1992;1248-1253.
40. Dakak N., Husain S., Mulcahy D., Andrews N.P., Panza J.A., Waclawiw M., Schenke W., Quyyumi A.A. Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction. Hypertension. 32:1998;9-15.
41. Davies M.J., Woolf N. Atherosclerosis: what is it and why does it occur? Br. Heart J. 69:1993;S3-S11. suppl.
42. De Meyer G.R.Y., Bult H. Mechanisms of neointima formation. Lessons from experimental models. Vasc. Med. 2:1997;179-189.
43. De Meyer G.R.Y., Bult H., Kockx M.M., Herman A.G. Effect of angiotensin converting-enzyme inhibition on intimal thickening in rabbit collared carotid artery. J. Cardiovasc. Pharmacol. 26:1995;614-620.
44. Delrio M., Chulia T., Ruiz E., Tejerina T. Action of probucol in arteries from normal and hypercholesterolaemic rabbits. Br. J. Pharmacol. 118:1996;1639-1644.
45. Diaz M.N., Frei B., Vita J.A., Keaney J.F. Jr. Antioxidants and atherosclerotic heart disease. N. Engl. J. Med. 337:1997;408-416.
46. Donetti E., Soma M.R., Barberi L., Paoletti R., Fumagalli R., Roma P., Catapano A.L. Dual effects of the antioxidant agents probucol and carvedilol on proliferative and fatty lesions in hypercholesterolemic rabbits. Atherosclerosis. 141:1998;45-51.
47. Dowell F.J., Hamilton C.A., Lindop G.B.M., Reid J.L. Development and progression of atherosclerosis in aorta from heterozygous and homozygous WHHL rabbits. Arterioscler. Thromb. Vasc. Biol. 15:1995;1152-1160.
48. Drexler H., Zeiher A.M., Meinzer K., Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 338:1991;1546-1550.
49. Durante W., Liao L., Iftikhar I., O'Brien W.E., Schafer A.I. Differential regulation of L-arginine transport and nitric oxide production by vascular smooth muscle and endothelium. Circ. Res. 78:1996;1075-1082.
50. Eichstadt H.W., Eskotter H., Hoffman I., Amthauer H.W., Weidinger G. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease. Am. J. Cardiol. 76:1995;122A-125A.
51. Elhage R., Bayard F., Richard V., Holvoet P., Duverger N., Fievet C., Arnal J.F. Prevention of fatty streak formation of 17beta-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice. Circulation. 96:1997;3048-3052.
52. Ericsson C.G., Hamsten A., Nilsson J., Grip L., Svane B., de Faire U. Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Lancet. 347:1996;849-853.
53. Farhat M.Y., Abi-Younes S., Ramwell P.W. Non-genomic effects of estrogen and the vessel wall. Biochem. Pharmacol. 51:1996;571-576.
54. Farhy R.D., Carretero O.A., Ho K.-L., Scicli A.G. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ. Res. 72:1993;1202-1210.
55. Fennessy P.A., Campbell J.H., Mendelsohn F.A., Campbell G.R. Angiotensin-converting enzyme inhibitors and atherosclerosis: relevance of animal models to human disease. Clin. Exp. Pharmacol. Physiol. 23:1996;S30-S32.
56. Feron O., Dessy C., Moniotte S., Desager J.P., Balligand J.L. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J. Clin. Invest. 103:1999;897-905.
57. Finta K.M., Fisher M.J., Lee L., Gordon D., Pitt B., Webb R.C. Ramipril prevents impaired endothelium-dependent relaxation in arteries from rabbits fed an atherogenic diet. Atherosclerosis. 100:1993;149-156.
58. Fisher M., Grotta J. New uses for calcium channel blockers. Therapeutic implications. Drugs. 46:1993;961-975.
59. Foegh M.L., Asotra S., Howell M.H., Ramwell P.W. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J. Vasc. Surg. 19:1994;722-726.
60. Freyschuss A., Xiu R.J., Zhang J., Ying X., Diczfalusy U., Jogestrand T., Henriksson P., Bjorkhem I. Vitamin C reduces cholesterol-induced microcirculatory changes in rabbits. Arterioscler. Thromb. Vasc. Biol. 17:1997;1178-1184.
61. Frick M., Elo O., Haapa K., Heinonen O.P., Heinsalmi P., Helo P., Huttunen J.K., Kaitaniemi P., Koskinen P., Manninen V., Mäenpää H., Malkönen M., Mänttäri M., Norola S., Pasternack A., Pikkarainen J., Romo M., Sjoblom T., Nikkilä E.A. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N. Engl. J. Med. 317:1987;1237-1245.
62. Frick M.H., Syvanne M., Nieminen M.S., Kauma H., Majahalme S., Virtanen V., Kesaniemi Y.A., Pasternack A., Taskinen M.R. Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Circulation. 96:1997;2137-2143.
63. Fruebis J., Bird D.A., Pattison J., Palinski W. Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants. J. Lipid Res. 38:1997;2455-2464.
64. Fruebis J., Gonzalez V., Silvestre M., Palinski W. Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 17:1997;1289-1302.
65. Geary R.L., Adams M.R., Benjamin M.E., Williams J.K. Conjugated equine estrogens inhibit progression of atherosclerosis but have no effect on internal hyperplasia or arterial remodeling induced by balloon catheter injury in monkeys. J. Am. Coll. Cardiol. 31:1998;1158-1164.
66. Gilligan D.M., Badar D.M., Panza J.A., Quyyumi A.A., Cannon R.O. Acute vascular effects of estrogen in postmenopausal women. Circulation. 90:1994;786-791.
67. Gilligan D.M., Sack M.N., Guetta V., Casino P.R., Quyyumi A.A., Rader D.J., Panza J.A., Cannon R.O. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. J. Am. Coll. Cardiol. 24:1994;1611-1617.
68. Gilligan D.M., Badar D.M., Panza J.A., Quyyumi A.A., Cannon R.O.I. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. Am. J. Cardiol. 75:1995;264-268.
69. Girerd X.J., Hirsch A.T., Cooke J.P., Dzau V.J., Creager M.A. L-Arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ. Res. 67:1990;1301-1308.
70. Giugliano D., Marfella R., Verrazzo G., Acampora R., Coppola L., Cozzolino D., D'Onofrio F. The vascular effects of L-arginine in humans. The role of endogenous insulin. J. Clin. Invest. 99:1997;433-438.
71. Godfried S.L., Combs G.F. Jr., Saroka J.M., Dillingham L.A. Potentiation of atherosclerotic lesions in rabbits by a high dietary level of vitamin E. Br. J. Nutr. 61:1989;607-617.
72. Goode G.K., Heagerty A.M. In vitro responses of human peripheral small arteries in hypercholesterolemia and effects of therapy. Circulation. 91:1995;2898-2903.
73. Guetta V., Quyyumi A.A., Prasad A., Panza J.A., Waclawiw M., Cannon R.O. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation. 96:1997;2795-2801.
74. Haak T., Haak E., Kusterer K., Weber A., Kohleisen M., Usadel K.H. Fenofibrate improves microcirculation in patients with hyperlipidemia. Eur. J. Med. Res. 3:1998;50-54.
75. Habib J.B., Bossaller C., Wells S., Williams C., Morrisett J.D., Henry P.D. Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110. Circ. Res. 58:1986;305-309.
76. Harrison D.G. Endothelial control of vasomotion and nitric oxide production: a potential target for risk factor management. Cardiol. Clin. 14:1996;1-15.
77. Harsch M., Braesen J.H., Niendorf A. Effects of low-dose pravastatin sodium on plasma cholesterol levels and aortic atherosclerosis of heterozygous WHHL rabbits fed a low cholesterol (0.03-percent) enriched diet for one year. Atherosclerosis. 128:1997;139-147.
78. Hayashi T., Yamada K., Esaki T., Mutoh E., Iguchi A. Effect of estrogen on isoforms of nitric oxide synthase: possible mechanism of antiatherosclerotic effect of estrogen. Gerontology. 43:1997;24-34.
79. Hayashi K., Imada T., Yamauchi T., Kido H., Shinyama H., Matzno S., Nakamura N., Kagitani Y. Possible mechanism for the antiatherosclerotic action of the calcium channel blocker AE0047 in cholesterol-fed rabbits. Clin. Exp. Pharmacol. Physiol. 25:1998;17-25.
80. Hayoz D., Weber R., Rutschmann B., Darioli R., Burnier M., Waeber B., Brunner H.R. Postischemic blood flow response in hypercholesterolemic patients. Hypertension. 26:1995;497-502.
81. Hecker M., Sessa W.C., Harris H.J., Ånggard E.E., Vane J.R. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. Proc. Natl. Acad. Sci. U.S.A. 87:1990;8612-8616.
82. Heitzer T., Just H., Münzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation. 94:1996;6-9.
83. Hernandez-Perera O., Perez-Sala D., Navarro-Antolin J., Sanchez-Pascuala R., Hernandez G., Diaz C., Lamas S. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J. Clin. Invest. 101:1998;2711-2719.
84. Hernandez-Presa M.A., Bustos C., Ortego M., Tunon J., Ortega L., Egido J. ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis. Am. J. Pathol. 153:1998;1825-1837.
85. Herrington D.M., Braden G.A., Williams J.K., Morgan T.M. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am. J. Cardiol. 73:1994;951-952.
86. Hickey H., Makdissi M., Hyland R., Wilks D., Dusting G.J. Perindopril treatment prevents the loss of endothelial nitric oxide function and development of neo-intima in rabbits. J. Mol. Cell. Cardiol. 28:1996;1985-1994.
87. Hodis H.N., Mack W.J., LaBree L., Cashin-Hemphill L., Sevanian A., Johnson R., Azen S.P. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA. 273:1995;1849-1854.
88. Holm P., Karsgaard N., Shalmi M., Andersen H.L., Hougaard P., Shouby S.O. Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits. J. Clin. Invest. 100:1997;821-828.
89. Holm P., Stender S., Andersen H.Ø., Hansen B.F., Nordestgaard B.G. Antiatherogenic effect of estrogen abolished by balloon catheter injury in cholesterol-clamped rabbits. Arterioscler. Thromb. Vasc. Biol. 17:1997;1504-1511.
90. Hope S., Brecher P., Chobanian A.V. Comparison of the effects of AT1 receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis. Am. J. Hypertens. 12:1999;28-34.
91. Hornig B., Arakawa N., Kohler C., Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation. 97:1998;363-368.
92. Hoshida S., Nishida M., Yamashita N., Igarashi J., Aoki K., Hori M., Kuzuya T., Tada M. Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits - effects of enalapril. Atherosclerosis. 130:1997;53-59.
93. Hoshida S., Yamashita N., Kawahara K., Kuzuya T., Hori M. Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis: possible mechanisms. Circulation. 99:1999;434-440.
94. Iafrati M.D., Karas R.H., Aronovitz M., Kim S., Sullivan T.R., Lubahn D.B., O'Donnell T.F., Korach K.S., Mendelsohn M.E. Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice. Nature Med. 3:1997;545-548.
95. Inoue N., Ohara Y., Fukai T., Harrison D.G., Nishida K. Probucol improves endothelial-dependent relaxation and decreases vascular superoxide production in cholesterol-fed rabbits. Am. J. Med. Sci. 315:1998;242-247.
96. Isner J.F., Kearney M., Bortman S., Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 91:1995;2703-2711.
97. Ito K., Akita H., Kanazawa K., Yamada S., Terashima M., Matsuda Y., Yokoyama M. Comparison of effects of ascorbic acid on endothelium-dependent vasodilation in patients with chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy versus patients with effort angina pectoris secondary to coronary artery disease. Am. J. Cardiol. 82:1998;762-767.
98. Janiak P., Libert O., Vilaine J.-P. Role of the renin-angiotensin system in neointima formation after injury in rabbits. Hypertension. 24:1994;671-678.
99. Jeremy R.W., McCarron H., Sullivan D. Effects of dietary L-arginine on atherosclerosis and endothelium-dependent vasodilatation in the hypercholesterolemic rabbit. Response according to treatment duration, anatomic site, and sex. Circulation. 94:1996;498-506.
100. John S., Schlaich M., Langenfeld M., Weihprecht H., Schmitz G., Weidinger G., Schmieder R.E. Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study. Circulation. 98:1998;211-216.
101. Jorge P.A., Ozaki M.R., Metze K. Effects of simvastatin and pravastatin on endothelium-dependent relaxation in hypercholesterolemic rabbits. Exp. Toxicol. Pathol. 46:1994;465-469.
102. Jost S., Rafflenbeul W., Deckers J., Wiese B., Hecker H., Nikutta P., Lippolt P., Lichtlen P. Concept of an antiatherosclerotic efficacy of calcium entry blockers. INTACT Investigators. Eur. J. Epidemiol. 8:1992;107-119. Suppl. 1.
103. Jukema J.W., van Boven A.J., Zwinderman A.H., van der Laarse A., Bruschke A.V. Proposed synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis. Cardiovasc. Drugs Ther. 12:1998;111-118. Suppl. 1.
104. Kamata K., Sugiura M., Kojima S., Kasuya Y. Preservation of endothelium-dependent relaxation in cholesterol-fed and streptozotocin-induced diabetic mice by the chronic administration of cholestyramine. Br. J. Pharmacol. 118:1996;385-391.
105. Kanazawa K., Kawashima S., Mikami S., Miwa Y., Hirata K.-I., Suematsu M., Hayashi Y., Itoh H., Yokoyama M. Endothelial constitutive nitric oxide synthase protein and mRNA increased in rabbit atherosclerotic aorta despite impaired endothelium-dependent vascular relaxation. Am. J. Pathol. 148:1996;1949-1956.
106. Kauser K., Sonnenberg D., Diel P., Rubanyi G. Effect of 17β-oestradiol on cytokine-induced nitric oxide production in rat isolated aorta. Br. J. Pharmacol. 118:1998;1089-1096.
107. Keaney J.F. Jr., Gaziano J.M., Xu A., Frei B., Curran-Celentano J., Shwaery G.T., Loscalzo J., Vita J.A. Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc. Natl. Acad. Sci. U.S.A. 90:1993;11880-11884.
108. Keaney J.F. Jr., Gaziano J.M., Xu A., Frei B., Curran-Celentano J., Shwaery G.T., Loscalzo J., Vita J.A. Low-dose α-tocopherol improves and high-dose α-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J. Clin. Invest. 93:1994;844-851.
109. Keaney J.F. Jr., Xu A., Cunningham D., Jackson T., Frei B., Vita J.A. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J. Clin. Invest. 95:1995;2520-2529.
110. Kockx M.M., De Meyer G.R.Y., Buyssens N., Jacob W., Bult H., Herman A.G. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation. 97:1998;2307-2315.
111. Kockx M.M., De Meyer G.R.Y., Buyssens N., Knaapen M.W.M., Bult H., Herman A.G. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ. Res. 83:1998;378-387.
112. Kovanen P.T. Chymase-containing mast cells in human arterial intima: implications for atherosclerotic disease. Heart Vessels Suppl. 12:1997;125-127.
113. Krasinski K., Spyridopoulos I., Asahara T., van der Zee R., Isner J.M., Losordo D.W. Estradiol accelerates functional endothelial recovery after arterial injury. Circulation. 95:1997;1768-1772.
114. Kritchevsky S.B., Shimakawa T., Tell G.S., Dennis B., Carpenter M., Eckfeldt J.H., Peacher-Ryan H., Heiss G. Dietary antioxidants and carotid artery wall thickness. The ARIC study. Circulation. 92:1995;2142-2150.
115. Kroon A.A., Stalenhoef A.F., Buikema H., Demacker P.N., de Wilde P.C., Leijten P.A., van Gilst W.H. The effect of cholesterol reduction on the endothelial function and progression of atherosclerosis in WHHL rabbits. Atherosclerosis. 103:1993;221-230.
116. Kunjara N.A., Thomson A.B., Kappagoda C.T. Effect of isradipine on the formation and regression of fatty streaks in cholesterol fed rabbits. Cardiovasc. Res. 28:1994;1089-1095.
117. Kuo L., Davis M.J., Cannon M.S., Chilian W.M. Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation. Restoration of endothelium-dependent responses by L-arginine. Circ. Res. 70:1992;465-476.
118. Laufs U., La F.V., Plutzky J., Liao J.K. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation. 97:1998;1129-1135.
119. Lee R.T., Libby P. The unstable atheroma. Arterioscler. Thromb. Vasc. Biol. 17:1997;1859-1867.
120. Leung W.H., Lau C.P., Wong C.K. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet. 341:1993;1496-1500.
121. Levine G.N., Frei B., Koulouris S.N., Gerhard M.D., Keaney J.F. Jr., Vita J.A. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 93:1996;1107-1113.
122. Lieberman E.H., Gerhard M.D., Uehata A., Walsh B.W., Selwyn A.P., Ganz P., Yeung A.C., Creager M.A. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann. Intern. Med. 121:1994;936-941.
123. Linz W., Wiemer G., Gohlke P., Unger T., Scholkens B.A. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol. Rev. 47:1995;25-49.
124. Luoma J.S., Strålin P., Marklund S.L., Hiltunen T.P., Särkioja T., Ylä-Herttuala S. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions. Colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler. Thromb. Vasc. Biol. 18:1998;157-167.
125. Mahfouz M.M., Kawano H., Kummerow F.A. Effect of cholesterol-rich diets with and without added vitamins E and C on the severity of atherosclerosis in rabbits. Am. J. Clin. Nutr. 66:1997;1240-1249.
126. Mancini G.B.J., Henry G.C., Macaya C., O'Neill B., Pucillo A.L., Carere R.G., Wargovich T.J., Mudra H., Lüscher T., Klibaner M.I., Haer H.E., Uprichard A.C.G., Pepine C.J., Pitt B. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The Trend (Trial on reversing endothelial dysfunction) study. Circulation. 94:1996;258-265.
127. Mao S.J., Yates M.T., Rechtin A.E., Jackson R.L., Van Sickle W.A. Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits. J. Med. Chem. 34:1991;298-302.
128. Markle R.A. Intrinsic focal variations of rabbit aortic hydrolase activities. Exp. Mol. Path. 51:1989;9-17.
129. Matthys K.E., Bult H. Nitric oxide function in atherosclerosis. Mediators Inflamm. 6:1997;3-21.
130. McDonald K.K., Zharikov S., Block E.R., Kilberg M.S. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the 'arginine paradox'. J. Biol. Chem. 272:1997;31213-31216.
131. McDowell I.F.W., Brennan G.M., McEneny J., Young I.S., Nicholls D.P., McVeigh G.E., Bruce I., Trimble E.R., Johnston G.D. The effect of probucol and vitamin E treatment on the oxidation of low-density lipoprotein and forearm vascular responses in humans. Eur. J. Clin. Invest. 24:1994;759-765.
132. Mitani H., Bandoh T., Ishikawa J., Kimura M., Totsuka T., Hayashi S. Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits. Br. J. Pharmacol. 119:1996;1269-1275.
133. Mohr S., McCormick T.S., Lapetina E.G. Macrophages resistant to endogenously generated nitric oxide-mediated apoptosis are hypersensitive to exogenously added nitric oxide donors: dichotomous apoptotic response independent of caspase 3 and reversal by the mitogen-activated protein kinase kinase (MEK) inhibitor PD 098059. Proc. Natl. Acad. Sci. U.S.A. 95:1998;5045-5050.
134. Moroi M., Zhang L., Yasuda T., Virmani R., Gold H.K., Fishman M.C., Huang P.L. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J. Clin. Invest. 101:1998;1225-1232.
135. Munday J.S., Thompson K.G., James K.A.C., Manktelow B.W. Dietary antioxidants do not reduce fatty streak formation in the C57BL/6 mouse atherosclerosis model. Arterioscler. Thromb. Vasc. Biol. 18:1998;114-119.
136. Mügge A., Riedel M., Barton M., Kuhn M., Lichtlen P. Endothelium independent relaxation of human coronary arteries by 17β-oestradiol in vitro. Cardiovasc. Res. 27:1993;1939-1942.
137. Münzel T., Sayegh H., Freeman B.A., Tarpey M.A., Harrison D.G. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. J. Clin. Invest. 95:1995;187-194.
138. Nathan L., Chaudhuri G. Estrogens and atherosclerosis. Annu. Rev. Pharmacol. Toxicol. 37:1997;477-515.
139. Nitenberg A., Paycha F., Ledoux S., Sachs R., Attali J.R., Valensi P. Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors. Circulation. 97:1998;736-743.
140. O'Driscoll G., Green D., Taylor R.R. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation. 95:1997;1126-1131.
141. Olsson A.G., Yuan X.M. Antioxidants in the prevention of atherosclerosis. Curr. Opin. Lipidol. 7:1996;374-380.
142. Oshima R., Ikeda T., Watanabe K., Itakura H., Sugiyama N. Probucol treatment attenuates the aortic atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Atherosclerosis. 137:1998;13-22.
143. Ozer N.K., Sirikci O., Taha S., San T., Moser U., Azzi A. Effect of vitamin E and probucol on dietary cholesterol-induced atherosclerosis in rabbits. Free Radic. Biol. Med. 24:1998;226-233.
144. Panagiotopoulos S., O'Brien R.C., Bucala R., Cooper M.E., Jerums G. Aminoguanidine has an antiatherogenic effect in the cholesterol-fed rabbit. Atherosclerosis. 136:1998;125-131.
145. Parker J.D., Parker J.O. Nitrate therapy for stable angina pectoris. N. Engl. J. Med. 338:1998;520-531.
146. Plotnick G.D., Corretti M.C., Vogel R.A. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. JAMA. 278:1997;1682-1686.
147. Prescott M.F., Sawyer W.K. ACE inhibition versus angiotensin II, AT1 receptor antagonism: a review of effects on intimal lesion formation in animal models of vascular injury, restenosis, and atherosclerosis. Drug Dev. Res. 29:1993;88-93.
148. Reis S.E., Gloth S.T., Blumenthal R.S., Resar J.R., Zacur H.A., Gerstenblith G., Brinker J.A. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 89:1994;52-60.
149. Riezebos J., Vleeming W., Beems R.B., van Amsterdam J.G.C., Meijer G.W., De Wildt D.J., Porsius A.J., Wemer J. Comparison of the antiatherogenic effects of isradipine and ramipril in cholesterol-fed rabbits: I. Effect on progression of atherosclerosis and endothelial dysfunction. J. Cardiovasc. Pharmacol. 23:1994;415-423.
150. Riezebos J., Vleeming W., Beems R.B., van Amsterdam J.G.C., Meijer G.W., De Wildt D.J., Porsius A.J., Wemer J. Comparison of the antiatherogenic effects of isradipine and ramipril in cholesterol-fed rabbits: II. Effect on regression of atherosclerosis and restoration of endothelial function. J. Cardiovasc. Pharmacol. 23:1994;424-431.
151. Rodes J., Cote G., Lesperance J., Bourassa M.G., Doucet S., Bilodeau L., Bertrand O.F., Harel F., Gallo R., Tardif J.C. Prevention of restenosis after angioplasty in small coronary arteries with probucol. Circulation. 97:1998;429-436.
152. Roqué M., Heras M., Borg E., Masotti M., Rigal M., Betrui A., Balasch J., Sanz G. Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms. J. Am. Coll. Cardiol. 31:1998;139-143.
153. Rosenkranz W.P., Sessa W.C., Milstien S., Kaufman S., Watson C.A., Pober J.S. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity [see comments]. J. Clin. Invest. 93:1994;2236-2243.
154. Rosenson R.S., Tangney C.C. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA. 279:1998;1643-1650.
155. Rosselli M., Imthurn B., Keller P.J., Jackson E.K., Dubey R.K. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study. Hypertension. 25:1995;848-853.
156. Rudic R.D., Shesely E.G., Maeda N., Smithies O., Segal S.S., Sessa W.C. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J. Clin. Invest. 101:1998;731-736.
157. Schroeder J.S., Gao S.Z., Alderman E.L., Hunt S.A., Johnstone I., Boothroyd D.B., Wiederhold V., Stinson E.B. A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N. Engl. J. Med. 328:1993;164-170.
158. Schuh J.R., Blehm D.J., Frierdich G.E., McMahon E.G., Blaine E.H. Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J. Clin. Invest. 91:1993;1453-1458.
159. Schwenke D.C., Behr S.R. Vitamin E combined with selenium inhibits atherosclerosis in hypercholesterolemic rabbits independently of effects on plasma cholesterol concentrations. Circ. Res. 83:1998;366-377.
160. Senaratne M.P., Thomson A.B., Kappagoda C.T. Lovastatin prevents the impairment of endothelium dependent relaxation and inhibits accumulation of cholesterol in the aorta in experimental atherosclerosis in rabbits. Cardiovasc. Res. 25:1991;568-578.
161. Shaish A., Daugherty A., O'Sullivan F., Schonfeld G., Heinecke J.W. Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. J. Clin. Invest. 96:1995;2075-2082.
162. Shibutani T., Kanda A., Ishigai Y., Mori T., Chiba K., Tanaka M., Tachezawa H. Inhibitory effect of perindopril, a novel angiotensin-converting enzyme inhibitor, on neointima formation after balloon injury in rats and cholesterol-fed rabbits. J. Cardiovasc. Pharmacol. 24:1994;509-516.
163. Singer A.H., Tsao P.S., Wang B.-Y., Bloch D.A., Cooke J.P. Discordant effects of dietary L-arginine on vascular structure and reactivity in hypercholesterolemic rabbits. J. Cardiovasc. Pharmacol. 25:1995;710-716.
164. Solzbach U., Hornig B., Jeserich M., Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation. 96:1997;1513-1519.
165. Soma M.R., Natali M., Donetti E., Baetta R., Farina P., Leonardo A., Comparato C., Barberi L., Catapano A.L. Effect of lercanidipine and its (R)-enantiomer on atherosclerotic lesions induced in hypercholesterolemic rabbits. Br. J. Pharmacol. 125:1998;1471-1476.
166. Song K., Shiota N., Takai S., Takashima H., Iwasaki H., Kim S., Miyazaki M. Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeys. Atherosclerosis. 138:1998;171-182.
167. Staels B., Dallongeville J., Auwerx J., Schoonjans K., Leitersdorf E., Fruchart J.-C. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 98:1998;2088-2093.
168. Staels B., Koenig W., Habib A., Merval R., Lebret M., Torra I.P., Delerive P., Fadel A., Chinetti G., Fruchart J.-C., Najib J., Maclouf J., Tedgui A. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators. Nature. 393:1998;790-793.
169. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheeseman K., Mitchinson M.J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 347:1996;781-786.
170. Stewart L.A., Forster L.A., Nourooz Z.J., Ferns G.A., Anggard E.E. Vitamin E protects against impairment of endothelium-mediated relaxations in cholesterol-fed rabbits. Arterioscler. Thromb. 14:1994;494-499.
171. Straznicky N.E., Howes L.G., Lam W., Louis W.J. Effects of pravastatin on cardiovascular reactivity to norepinephrine and angiotensin II in patients with hypercholesterolemia and systemic hypertension. Am. J. Cardiol. 75:1995;582-586.
172. Stroes E.S., Koomans H.A., de B.T., Rabelink T.J. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet. 346:1995;467-471.
173. Stroes E., Kastelein J., Cosentino F., Erkelens W., Wever R., Koomans H., Lüscher T., Rabelink T. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J. Clin. Invest. 99:1997;41-46.
174. Sugano M., Makino N., Yanaga T. The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits. Atherosclerosis. 127:1996;123-129.
175. Sun Y.P., Zhu B.Q., Sievers R.E., Norkus E.P., Parmley W.W., Deedwania P.C. Effects of antioxidant vitamins C and E on atherosclerosis in lipid-fed rabbits. Cardiology. 89:1998;189-194.
176. Tagawa H., Shimokawa H., Tagawa T., Kuroiwa-Matsumoto M., Hirooka Y., Takeshita A. Short-term estrogen augments both nitric-oxide mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilation in postmenopausal women. J. Cardiovasc. Pharmacol. 30:1997;481-488.
177. Takai S., Shiota N., Kobayashi S., Matsumura E., Miyazaki M. Induction of chymase that forms angiotensin II in the monkey atherosclerotic aorta. FEBS Lett. 412:1997;86-90.
178. Tamai O., Matsuoka H., Itabe H., Wada Y., Kohno K., Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation. 95:1997;76-82.
179. Tanaka K., Hayashi K., Shingu T., Kuga Y., Nomura K., Kajiyama G. Probucol inhibits neointimal formation in carotid arteries of normocholesterolemic rabbits and the proliferation of cultured rabbit vascular smooth muscle cells. Cardiovasc. Drugs Ther. 12:1998;19-28.
180. Tardif J.C., Cote G., Lesperance J., Bourassa M., Lambert J., Doucet S., Bilodeau L., Nattel S., de Guise P. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N. Engl. J. Med. 337:1997;365-372.
181. Timimi F.K., Ting H.H., Haley E.A., Roddy M.A., Ganz P., Creager M.A. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 31:1998;552-557.
182. Ting H.H., Timimi F.K., Haley E.A., Roddy M.A., Ganz P., Creager M.A. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 95:1997;2617-2622.
183. Traub O., Berk B.C. Laminar shear stress. Mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler. Thromb. Vasc. Biol. 18:1998;677-685.
184. Tronc F., Wassef M., Esposito B., Henrion D., Glagov S., Tedgui A. Role of NO in flow-induced remodeling of the rabbit common carotid artery. Arterioscler. Thromb. Vasc. Biol. 16:1996;1256-1262.
185. Urakami Harasawa L., Shimokawa H., Nakashima M., Egashira K., Takeshita A. Importance of endothelium-derived hyperpolarizing factor in human arteries. J. Clin. Invest. 100:1997;2793-2799.
186. van Boven A.J., Jukema J.W., Zwinderman A.H., Crijns H.J., Lie K.I., Bruschke A.V. Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group. Circulation. 94:1996;1503-1505.
187. Verbeuren T.J., Bonhomme E., Laubie M., Simonet S. Evidence for induction of non-endothelial NO-synthase in aortas of cholesterol-fed rabbits. J. Cardiovasc. Pharmacol. 21:1993;841-845.
188. Verhaar M.C., Wever R.M.F., Kastelein J.J.P., van Dam T., Koomans H.A., Rabelink T.J. 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation. 97:1998;237-241.
189. Vita J.A., Frei B., Holbrook M., Gokce N., Leaf C., Keaney J.J. L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J. Clin. Invest. 101:1998;1408-1414.
190. Vita J.A., Keaney J.F. Jr., Raby K.E., Morrow J.D., Freedman J.E., Lynch S., Koulouris S.N., Hankin B.R., Frei B. Low plasma ascorbic acid independently predicts the presence of an unstable coronary syndrome. J. Am. Coll. Cardiol. 31:1998;980-986.
191. Vogel R.A., Corretti M.C., Plotnick G.D. Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men. Am. J. Cardiol. 77:1996;37-40.
192. Walldius G., Erikson U., Olsson A.G., Hådell K., Johansson J., Kaijser L., Lassvik C., Molgaard J., Nilsson S. The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST). Am. J. Cardiol. 74:1994;875-883.
193. Wascher T.C., Posch K., Wallner S., Hermetter A., Kostner G.M., Graier W.F. Vascular effects of L-arginine: anything beyond a substrate for the NO-synthase? Biochem. Biophys. Res. Commun. 234:1997;35-38.
194. Weber C., Erl W., Pietsch A., Strobel M., Ziegler H.H., Weber P.C. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler. Thromb. 14:1994;1665-1673.
195. White C.R., Brock T.A., Chang L.Y., Crapo J., Briscoe P., Ku D., Bradley W.A., Gianturco S.H., Gore J., Freeman B.A.et al. Superoxide and peroxynitrite in atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 91:1994;1044-1048.
196. White C.R., Shelton J., Chen S.J., Darley-Usmar V., Allen L., Nabors C., Sanders P.W., Chen Y.F., Oparil S. Estrogen restores endothelial cell function in an experimental model of vascular injury. Circulation. 96:1997;1624-1630.
197. Wilcox J.N., Subramanian R.R., Sundell C.L., Tracey W.R., Pollock J.S., Harrison D.G., Marsden P.A. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler. Thromb. Vasc. Biol. 17:1997;2479-2488.
198. Witztum J.L. The oxidation hypothesis of atherosclerosis. Lancet. 344:1994;793-795.
199. Yamamoto A., Hoshi K., Ichihara K. Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes. Eur. J. Pharmacol. 361:1998;143-149.
200. Yin Z.L., Dusting G.J. A nitric oxide donor (spermine-NONOate) prevents the formation of neointima in rabbit carotid artery. Clin. Exp. Pharmacol. Physiol. 24:1997;436-438.